{
    "2020-06-18": [
        [
            {
                "time": "",
                "original_text": "百安居引入上上签 电子签名为供应链赋能",
                "features": {
                    "keywords": [
                        "百安居",
                        "上上签",
                        "电子签名",
                        "供应链"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "零售",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)子公司抗癫痫药获得美国FDA暂时批准文号",
                "features": {
                    "keywords": [
                        "上海医药",
                        "抗癫痫药",
                        "FDA",
                        "批准文号"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "羟氯喹治疗新冠试验停止 药企：影响不大",
                "features": {
                    "keywords": [
                        "羟氯喹",
                        "新冠",
                        "试验停止",
                        "药企"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：控股子公司产品获得美国FDA暂时批准文号",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股子公司",
                        "FDA",
                        "批准文号"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)：控股子公司产品获美国FDA暂时批准文号",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股子公司",
                        "FDA",
                        "批准文号"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业大洗牌，16家药企被并了！",
                "features": {
                    "keywords": [
                        "医药行业",
                        "洗牌",
                        "药企",
                        "并购"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}